PL3325081T3 - Sposoby dostarczania limfatycznego środków czynnych - Google Patents
Sposoby dostarczania limfatycznego środków czynnychInfo
- Publication number
- PL3325081T3 PL3325081T3 PL16831144T PL16831144T PL3325081T3 PL 3325081 T3 PL3325081 T3 PL 3325081T3 PL 16831144 T PL16831144 T PL 16831144T PL 16831144 T PL16831144 T PL 16831144T PL 3325081 T3 PL3325081 T3 PL 3325081T3
- Authority
- PL
- Poland
- Prior art keywords
- methods
- active agents
- lymphatic delivery
- lymphatic
- delivery
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title 1
- 230000001926 lymphatic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/003—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a lumen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0061—Methods for using microneedles
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562196558P | 2015-07-24 | 2015-07-24 | |
US201562196568P | 2015-07-24 | 2015-07-24 | |
PCT/US2016/043656 WO2017019535A2 (en) | 2015-07-24 | 2016-07-22 | Methods for lymphatic delivery of active agents |
EP16831144.7A EP3325081B1 (en) | 2015-07-24 | 2016-07-22 | Methods for lymphatic delivery of active agents |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3325081T3 true PL3325081T3 (pl) | 2021-12-20 |
Family
ID=57885089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL16831144T PL3325081T3 (pl) | 2015-07-24 | 2016-07-22 | Sposoby dostarczania limfatycznego środków czynnych |
Country Status (15)
Country | Link |
---|---|
US (3) | US10737082B2 (pl) |
EP (2) | EP3922238A1 (pl) |
JP (3) | JP6929829B2 (pl) |
KR (1) | KR20180035210A (pl) |
CN (1) | CN107949418B (pl) |
AU (3) | AU2016297832B2 (pl) |
BR (1) | BR112018001435A2 (pl) |
CA (1) | CA2991459A1 (pl) |
DK (1) | DK3325081T3 (pl) |
ES (1) | ES2893673T3 (pl) |
HU (1) | HUE056424T2 (pl) |
MX (2) | MX2018000126A (pl) |
PL (1) | PL3325081T3 (pl) |
RU (1) | RU2719946C2 (pl) |
WO (1) | WO2017019535A2 (pl) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112018001435A2 (pt) * | 2015-07-24 | 2018-09-11 | Kimberly Clark Co | métodos para entrega linfática de agentes ativos |
WO2017019526A2 (en) * | 2015-07-24 | 2017-02-02 | Kimberly-Clark Worldwide, Inc. | Methods for better delivery of active agents to tumors |
EP3677283A4 (en) * | 2017-08-31 | 2021-05-12 | Tohoku University | APPROPRIATE AREA OF OSMOTIC PRESSURE OF A SOLUTION WITH MEDICINAL PRODUCT EFFECTIVE IN LYMPHODIC DELIVERY SYSTEM |
AU2020397052A1 (en) | 2019-12-05 | 2022-07-14 | Vivasor, Inc. | Method of treating cancer by administration of an anti-PD-1 or anti-PD-L1 therapeutic agent via a lymphatic delivery device |
JP7509402B2 (ja) | 2020-02-26 | 2024-07-02 | 国立大学法人 和歌山大学 | 解析装置、センシングシステム、解析装置の動作方法、及び、コンピュータプログラム |
WO2022159736A1 (en) | 2021-01-22 | 2022-07-28 | Sorrento Therapeutics, Inc. | Device for microliter-scale lymphatic delivery of coronavirus vaccines |
WO2022192594A2 (en) | 2021-03-11 | 2022-09-15 | Sorrento Therapeutics, Inc. | Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease |
EP4352100A1 (en) | 2021-06-09 | 2024-04-17 | Sorrento Therapeutics, Inc. | Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device |
CN113368385A (zh) * | 2021-06-21 | 2021-09-10 | 温州医科大学慈溪生物医药研究院 | 利用淋巴通路递送生物大分子药物入脑的输送*** |
AU2022329961A1 (en) | 2021-08-18 | 2024-03-28 | Vivasor, Inc. | Therapeutic agents targeting the lymphatic system |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
US6503231B1 (en) * | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
US20020095134A1 (en) | 1999-10-14 | 2002-07-18 | Pettis Ronald J. | Method for altering drug pharmacokinetics based on medical delivery platform |
DE60101206T2 (de) * | 2000-06-01 | 2004-09-02 | Watson Pharmaceuticals, Inc., Corona | Transdermale verabreichung von lasofoxifen |
WO2003022330A2 (en) * | 2001-09-12 | 2003-03-20 | Becton, Dickinson And Company | Microneedle-based pen device for drug delivery and method for using same |
AU2004206853A1 (en) | 2003-01-16 | 2004-08-05 | Becton, Dickinson And Company | Intradermal cellular delivery using narrow gauge micro-cannula |
US20050163711A1 (en) | 2003-06-13 | 2005-07-28 | Becton, Dickinson And Company, Inc. | Intra-dermal delivery of biologically active agents |
CA2536669A1 (en) | 2003-08-26 | 2005-03-17 | Becton, Dickinson And Company | Methods for intradermal delivery of therapeutics agents |
WO2006127962A2 (en) * | 2005-05-25 | 2006-11-30 | Becton, Dickinson And Comapny | Particulate formulations for intradermal delivery of biologically active agents |
ES2556974T3 (es) | 2005-08-12 | 2016-01-21 | Jiang Liu | Dispositivos para la orientación al sistema linfático |
US20070087029A1 (en) | 2005-10-14 | 2007-04-19 | Pakala Syamasundar V | Localized delivery to the lymphatic system |
US8197435B2 (en) * | 2006-05-02 | 2012-06-12 | Emory University | Methods and devices for drug delivery to ocular tissue using microneedle |
WO2008038140A2 (en) | 2006-06-07 | 2008-04-03 | Foamix Ltd. | Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof |
EP2100850A1 (en) * | 2008-03-11 | 2009-09-16 | Stichting Voor De Technische Wetenschappen | Microneedle array and a method for manufacturing microneedles |
US20110150765A1 (en) * | 2008-10-31 | 2011-06-23 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Frozen compositions and methods for piercing a substrate |
WO2012046149A1 (en) | 2010-04-28 | 2012-04-12 | Kimberly-Clark Worldwide, Inc. | Method for increasing permeability of an epithelial barrier |
CN102958556B (zh) | 2010-04-28 | 2017-02-15 | 金伯利-克拉克环球有限公司 | 细胞相互作用增强的纳米图案化医疗装置 |
CN102985131B (zh) | 2010-04-28 | 2016-06-29 | 金伯利-克拉克环球有限公司 | 用于递送siRNA的医疗装置 |
CN102971037B (zh) | 2010-04-28 | 2016-05-25 | 金伯利-克拉克环球有限公司 | 用于递送类风湿性关节炎药物的装置 |
US20120187814A1 (en) | 2011-01-25 | 2012-07-26 | Fryling Nicholas A | Furniture System and a Frame Assembly for a Furniture System |
US20120245445A1 (en) * | 2011-03-21 | 2012-09-27 | Michael Darryl Black | Glucose Monitoring System |
JP6219832B2 (ja) * | 2011-10-17 | 2017-10-25 | マサチューセッツ インスティテュート オブ テクノロジー | 細胞内送達 |
RU2630610C2 (ru) | 2011-10-27 | 2017-09-11 | Кимберли-Кларк Ворлдвайд, Инк. | Трансдермальная доставка высоковязких биоактивных агентов |
US20170246439A9 (en) | 2011-10-27 | 2017-08-31 | Kimberly-Clark Worldwide, Inc. | Increased Bioavailability of Transdermally Delivered Agents |
CN104703651A (zh) * | 2012-05-01 | 2015-06-10 | 高等教育联邦***-匹兹堡大学 | 用于经皮***的尖端负载的微针阵列 |
EP2961469A4 (en) | 2013-02-28 | 2016-10-26 | Kimberly Clark Co | DEVICE FOR DELIVERY OF MEDICAMENT |
KR102370538B1 (ko) | 2013-02-28 | 2022-03-07 | 소렌토 쎄라퓨틱스, 인코포레이티드 | 경피 약물 전달 장치 |
JP2016517762A (ja) | 2013-05-23 | 2016-06-20 | キンバリー クラーク ワールドワイド インコーポレイテッド | 開放チャネル断面形状が改善されたマイクロニードル |
BR112018001435A2 (pt) * | 2015-07-24 | 2018-09-11 | Kimberly Clark Co | métodos para entrega linfática de agentes ativos |
WO2017019526A2 (en) * | 2015-07-24 | 2017-02-02 | Kimberly-Clark Worldwide, Inc. | Methods for better delivery of active agents to tumors |
-
2016
- 2016-07-22 BR BR112018001435A patent/BR112018001435A2/pt not_active Application Discontinuation
- 2016-07-22 AU AU2016297832A patent/AU2016297832B2/en active Active
- 2016-07-22 HU HUE16831144A patent/HUE056424T2/hu unknown
- 2016-07-22 ES ES16831144T patent/ES2893673T3/es active Active
- 2016-07-22 RU RU2018104104A patent/RU2719946C2/ru active
- 2016-07-22 KR KR1020187003327A patent/KR20180035210A/ko not_active Application Discontinuation
- 2016-07-22 WO PCT/US2016/043656 patent/WO2017019535A2/en active Application Filing
- 2016-07-22 DK DK16831144.7T patent/DK3325081T3/da active
- 2016-07-22 JP JP2018500418A patent/JP6929829B2/ja active Active
- 2016-07-22 CN CN201680050966.3A patent/CN107949418B/zh active Active
- 2016-07-22 EP EP21189701.2A patent/EP3922238A1/en active Pending
- 2016-07-22 PL PL16831144T patent/PL3325081T3/pl unknown
- 2016-07-22 MX MX2018000126A patent/MX2018000126A/es unknown
- 2016-07-22 EP EP16831144.7A patent/EP3325081B1/en active Active
- 2016-07-22 CA CA2991459A patent/CA2991459A1/en active Pending
- 2016-07-22 US US15/744,385 patent/US10737082B2/en active Active
-
2018
- 2018-01-08 MX MX2022014634A patent/MX2022014634A/es unknown
-
2020
- 2020-07-10 US US16/925,548 patent/US20200338329A1/en not_active Abandoned
- 2020-09-18 AU AU2020233748A patent/AU2020233748B2/en active Active
-
2021
- 2021-08-11 JP JP2021131298A patent/JP7167272B2/ja active Active
-
2022
- 2022-10-26 JP JP2022171479A patent/JP2023015135A/ja active Pending
- 2022-11-21 AU AU2022275393A patent/AU2022275393A1/en active Pending
-
2024
- 2024-02-15 US US18/442,568 patent/US20240181235A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2021185160A (ja) | 2021-12-09 |
AU2022275393A1 (en) | 2023-01-05 |
CA2991459A1 (en) | 2017-02-02 |
AU2016297832A1 (en) | 2018-02-15 |
EP3325081A4 (en) | 2019-04-10 |
JP2023015135A (ja) | 2023-01-31 |
US10737082B2 (en) | 2020-08-11 |
RU2719946C2 (ru) | 2020-04-23 |
JP7167272B2 (ja) | 2022-11-08 |
JP2018522002A (ja) | 2018-08-09 |
RU2018104104A3 (pl) | 2019-10-31 |
RU2018104104A (ru) | 2019-08-26 |
US20240181235A1 (en) | 2024-06-06 |
ES2893673T3 (es) | 2022-02-09 |
JP6929829B2 (ja) | 2021-09-01 |
CN107949418B (zh) | 2024-07-02 |
WO2017019535A2 (en) | 2017-02-02 |
CN107949418A (zh) | 2018-04-20 |
DK3325081T3 (da) | 2021-10-11 |
AU2016297832B2 (en) | 2020-07-16 |
EP3325081A2 (en) | 2018-05-30 |
EP3922238A1 (en) | 2021-12-15 |
MX2018000126A (es) | 2018-03-23 |
US20180193625A1 (en) | 2018-07-12 |
US20200338329A1 (en) | 2020-10-29 |
MX2022014634A (es) | 2023-01-18 |
KR20180035210A (ko) | 2018-04-05 |
EP3325081B1 (en) | 2021-09-08 |
HUE056424T2 (hu) | 2022-02-28 |
BR112018001435A2 (pt) | 2018-09-11 |
AU2020233748A1 (en) | 2020-10-08 |
AU2020233748B2 (en) | 2022-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1256383A1 (zh) | 治療劑 | |
IL249837B (en) | An inhaler for administering active substances through the lungs | |
LT3386484T (lt) | Gydomųjų medžiagų sudėtis ir pristatymo metodai | |
HUE056424T2 (hu) | Eljárások hatóanyagoknak a nyirokrendszerbe való bejuttatására | |
GB201701039D0 (en) | Vertically integrated continuous delivery of an application | |
IL241064A0 (en) | An array with a microstructure for the introduction of active substances | |
ZA201903467B (en) | Transdermal delivery of large agents | |
GB201509893D0 (en) | Therapeutic agents | |
IL249455A0 (en) | Complexes of mineral-amino acids with active substances | |
HUE056410T2 (hu) | Eljárások a hatóanyagok jobb bejuttatására a tumorokba | |
GB201517263D0 (en) | Therapeutic agents | |
GB201410816D0 (en) | Therapeutic agents | |
EP3405151A4 (en) | IMPROVED TRANSDERMAL DISTRIBUTION OF ACTIVE SUBSTANCES | |
GB201410815D0 (en) | Therapeutic agents | |
GB201410817D0 (en) | Therapeutic agents | |
HK1245639A1 (zh) | 纖維化病治療劑 | |
GB201509885D0 (en) | Therapeutic agents | |
GB201509888D0 (en) | Therapeutic agents | |
ZA201800163B (en) | New anti-malarial agents | |
EP3094347A4 (en) | Methods for enhancing the delivery of active agents | |
GB201513299D0 (en) | Therapeutic agents | |
GB201410507D0 (en) | Drug delivery enhancement agents | |
GB201521767D0 (en) | Therapeutic agents | |
GB201409653D0 (en) | Pyrrolobenzodiazepine therapeutic agents | |
GB201517264D0 (en) | Therapeutic agents |